Skip to content
★ Sign in to follow
JPI Healthcare Co.,Ltd. logo

JPI Healthcare Co.,Ltd. Stock: price and insider trades · South Korea

제이피아이헬스케어

KR·Mcap ₩40.1BHealth Care

No insider purchase over the last 90 days. The latest, by 이승혜, was filed 27 Jul 2026.

JPI Healthcare Co.,Ltd.: what insiders have been doing

JPI Healthcare Co.,Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). The last twelve months, up to 2 November 2026, brought 5 filings signed by 2 insiders.

Open-market activity splits into 4 purchases and 1 sale; 1 insider sit on the buying side and 1 insider on the selling side. The totals do not cover 5 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.

The most recent open-market purchase was published on 27 July 2026, 106 days ago.

For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 5 filings here. Over the whole record (from 2025), the tally stands at 8 purchases and 1 sale.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
9
Thresholds
n/a
Buy Volume
€70M
8 ops. · all time
Sell Volume
€273,221
1 ops. · all time

Who traded when

BuySale
이승혜4 buys
와이제이에이헬스케어성장지원사모투자2 buys1 sale
김진국2 buys

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 3,279 of 26,911 companies
72.3
score / 100
Value
79
Quality
66
FCF yld5.4%
Earn yld14%
EV/EBITDA6.6x
ROE13%
Gross mgn42%
Net mgn11%
Debt/EBITDA1.6x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩7,850
Analyst consensus
·
Income statement
Revenue₩48.5B
Gross profit₩20.3B42% margin
EBITDA₩7.6B16% margin
Net income₩5.3B15.0% margin
Balance sheet & cash
Market cap₩40.1B
Total debt₩11.8B
Free Cash Flow₩2B
Debt / Equity17%
Profitability & ownership
ROE12.6%
ROA3.9%
% insiders67.8%
% institutions0.1%
Last declaration on 27 July 2026
Declarations9 total
  • ▲
    10%이상주주Executives(filed)
    €1,677est.0DART
    350 sharesShareKRXDART:20260727000108
    Canonical exit: 25 Oct 2026 (T+90)
  • ▲
    10%이상주주Executives(filed)
    €16kest.0DART
    3,430 sharesShareKRXDART:20260715000377
    Canonical exit: 13 Oct 2026 (T+90)
  • ▲
    10%이상주주Executives(filed)
    €8,994est.0DART
    2,130 sharesShareKRXDART:20260625000330
    Canonical exit: 23 Sept 2026 (T+90)
  • ▲
    -Executives
    €3.8Mest.0DART
    560,000 sharesShareKRXDART:20260507000162
    Canonical exit: 19 Nov 2025 (T+90)
  • ▼
    10%이상주주Executives(filed)
    €273kest.0DART
    26,980 sharesShareKRXDART:20251208000322
  • ▲
    대량보유자Executives
    €16.0Mest.0DART
    1,558,000 sharesKRXDART:20250826000269
    Canonical exit: 19 Nov 2025 (T+90)
  • ▲
    대표이사Executives(filed)
    €13.5Mest.0DART
    1,312,000 sharesShareKRXDART:20250826000255
    Canonical exit: 24 Nov 2025 (T+90)
  • ▲
    대량보유자Executives
    €20.4Mest.0DART
    1,980,000 sharesKRXDART:20250826000259
    Canonical exit: 19 Nov 2025 (T+90)
  • ▲
    10%이상주주Executives(filed)
    €16.0Mest.0DART
    1,558,000 sharesShareKRXDART:20250826000265
    Canonical exit: 24 Nov 2025 (T+90)

9 of 9 declarations

About JPI Healthcare Co.,Ltd.

제이피아이헬스케어 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and provision of innovative health solutions.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations